a strong trendp=0.06
The comparison of CI-rate incidence of NEC in patients treated with CPX-351 (ind1) vs 7 + 3 (ida) showed a strong trend (p=0.06).
The comparison of CI-rate incidence of NEC in patients treated with CPX-351 (ind1) vs 7 + 3 (ida) showed a strong trend (p=0.06).